United States · 
Who invested in Exo Therapeutics?
Exo Therapeutics's investors include CRV, Casdin Capital and Samsara BioCapital.
United States · Series B startup
Who invested in Exo Therapeutics
One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Exo Therapeutics and see its new rounds in your feed.Start following
Funding summaryUpdated 27 Oct 2026
$78Mraised across 1 round since 2021, from 1 source
- Latest round
- Series B, $78MOct 2021
- Investors
- 3
The rounds
- Oct 2021
Founders and team
From Exo Therapeutics's own website: 4 on the team.
- Dorothy Lou BaileyPresident & CEO
- Weill Cornell Medical CollegePhysician-in-Chief Emeritus at Hospital for Special Surgery
- Bob FayExecutive Project Manager
- Lindsey ArnoldHR and Operations Manager
AdvisersAlexandra Joseph
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
These 2 firms list Exo Therapeutics as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Exo Therapeutics
How much has Exo Therapeutics raised?
Exo Therapeutics has raised $78M across 1 round since 2021.
When did Exo Therapeutics last raise?
Exo Therapeutics's most recent round was a Series B of $78M in Oct 2021.
What was Exo Therapeutics's biggest round?
Its most recent round, $78M in Oct 2021, is also its largest on record.
Who backed Exo Therapeutics first?
Exo Therapeutics's first round on record, in Oct 2021, was backed by CRV, Casdin Capital and Samsara BioCapital.
What stage is Exo Therapeutics at?
Exo Therapeutics's latest named round is a Series B, in Oct 2021.
Where is Exo Therapeutics based?
Exo Therapeutics is based in the United States.
Companies like Exo Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.